Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.83B |
| Enterprise Value | 1.16B |
| P/E Ratio | -3.1 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 30.8 |
| Price/Book Ratio | 1.87 |
| Enterprise/Revenue | 21.98 |
| Enterprise/EBITDA | -2.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -9.46 |
| Operating Margin | -9.92 |
| Return On Assets | -0.43 |
| Return On Equity | -0.5 |
| Revenue | 74.68M |
| Revenue/Share | 0.1 |
| Gross Profit | -46.27M |
| EBITDA | -559.38M |
| Net Income | -644.76M |
| Diluted EPS | -1.44 |
| Total Cash | 545.68M |
| Total Cash/Share | 1.02 |
| Total Debt | 61.89M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 5.03 |
| Book Value Per Share | 1.72 |
| 52-Week Change | -39.13 |
| 52-Week High | 7.18 |
| 52-Week Low | 2.77 |
| Moving Average 50 Days | 3.32 |
| Moving Average 200 Days | 3.83 |
| Average Volume | 20.94M |
| Shares Outstanding | 524.68M |
| % Held by Institutions | 75.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |